Literature DB >> 1359220

Tamoxifen: disease prevention or disease substitution?

A Fugh-Berman1, S Epstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1359220     DOI： 10.1016/0140-6736(92)93161-f

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer.

Authors:  Jamal Zidan; Zohar Keidar; Walid Basher; Ora Israel
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

Review 2.  Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.

Authors:  H M Bryson; G L Plosker
Journal:  Pharmacoeconomics       Date:  1993-07       Impact factor: 4.981

Review 3.  Tamoxifen and secondary tumours. An update.

Authors:  N Wilking; E Isaksson; E von Schoultz
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

Review 4.  Gynecologic effects of tamoxifen: case reports and review of the literature.

Authors:  R M Caputo; L J Copeland
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

Review 5.  Advocacy groups for breast cancer patients.

Authors:  M Waller; S Batt
Journal:  CMAJ       Date:  1995-03-15       Impact factor: 8.262

Review 6.  Tamoxifen as adjuvant therapy in breast cancer. Current status.

Authors:  P N Plowman
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

7.  The incidence of hepatocellular carcinoma in US white women with breast cancer after the introduction of tamoxifen in 1977.

Authors:  K Mühlemann; L S Cook; N S Weiss
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Chronic active hepatitis and liver cirrhosis in association with combined tamoxifen/tegafur adjuvant therapy.

Authors:  S Maruyama; C Hirayama; J Abe; J Tanaka; K Matsui
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

9.  The Royal Marsden Hospital pilot tamoxifen chemoprevention trial.

Authors:  T J Powles; A L Jones; S E Ashley; M E O'Brien; V A Tidy; J Treleavan; D Cosgrove; A G Nash; N Sacks; M Baum
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Endometrial pathology in breast cancer patients: Effect of different treatments on ultrasonographic, hysteroscopic and histological findings.

Authors:  Maria LE Donne; Angela Alibrandi; Leonarda Ciancimino; Andrea Azzerboni; Benito Chiofalo; Onofrio Triolo
Journal:  Oncol Lett       Date:  2013-01-28       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.